ANTIBIOTIC RESPONSIVE DEMYELINATING NEUROPATHY RELATED TO LYME DISEASE
Citation Manager Formats
Make Comment
See Comments
This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
To the Editor:
Neuropathies in Lyme disease—or the European version “borreliosis”— remain an enigma. We agree with the authors that demyelinating neuropathy in the context of Lyme disease has not been well documented, and it remains unclear whether the occurrence of the neuropathy and the diagnosis of Lyme disease is a chance association.1
We see many patients with neuroborreliosis in Austria where borreliosis infections are frequent. Polyradiculopathy, sometimes associated with cranial nerves, appears to be the clinical hallmark. CSF findings include pleocytosis, lymphocytes at various stages of activation, and monocytes. A negative CSF finding rules out the diagnosis.
Apart from the serologic diagnosis, electrophysiology often indicates radiculopathy, yet axonal damage and denervation …
AAN Members
We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.
AAN Non-Member Subscribers
Purchase access
For assistance, please contact:
AAN Members (800) 879-1960 or (612) 928-6000 (International)
Non-AAN Member subscribers (800) 638-3030 or (301) 223-2300 option 3, select 1 (international)
Sign Up
Information on how to subscribe to Neurology and Neurology: Clinical Practice can be found here
Purchase
Individual access to articles is available through the Add to Cart option on the article page. Access for 1 day (from the computer you are currently using) is US$ 39.00. Pay-per-view content is for the use of the payee only, and content may not be further distributed by print or electronic means. The payee may view, download, and/or print the article for his/her personal, scholarly, research, and educational use. Distributing copies (electronic or otherwise) of the article is not allowed.
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Long-term Safety and Efficacy of Avalglucosidase Alfa in Patients With Late-Onset Pompe Disease
Dr. Marianne de Visser and Dr. Maudy Theunissen
► Watch
Related Articles
- No related articles found.
Alert Me
Recommended articles
-
Special Article
Clinical Practice Guidelines by the Infectious Diseases Society of America, American Academy of Neurology, and American College of Rheumatology2020 Guidelines for the Prevention, Diagnosis, and Treatment of Lyme DiseasePaul M. Lantos, Jeffrey Rumbaugh, Linda K. Bockenstedt et al.Neurology, November 30, 2020 -
VIEWS AND REVIEWS
Practice parameters for the diagnosis of patients with nervous system Lyme borreliosis (Lyme disease)John J. Halperin, Eric L. Logigian, Michael F. Finkel et al.Neurology, March 01, 1996 -
Special Article
Practice Parameter: Treatment of nervous system Lyme disease (an evidence-based review): Report of the Quality Standards Subcommittee of the American Academy of NeurologyJ. J. Halperin, E. D. Shapiro, E. Logigian et al.Neurology, May 23, 2007 -
Articles
Relevance of the antibody index to diagnose Lyme neuroborreliosis among seropositive patientsF. Blanc, B. Jaulhac, M. Fleury et al.Neurology, September 04, 2007